Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06605924 · ClinicalTrials.gov registry record · NA
Oral Nicotine Pouch Marketing Features Influence on Perceptions
A NA study, sponsored by Johns Hopkins Bloomberg School of Public Health.
- Completed
- Registry status
- NA
- Development phase
- 5,133
- Enrollment target
NCT06605924: Completed NA study, sponsored by Johns Hopkins Bloomberg School of Public Health.
NCT06605924 is a NA study that has completed, run by Johns Hopkins Bloomberg School of Public Health. The registered enrollment target is 5,133 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (266% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06605924, a NA study, has completed, sponsored by Johns Hopkins Bloomberg School of Public Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 5,133 participants
- Enrollment target
Study Summary
This study tests the effects of three oral nicotine marketing features on product perceptions.
Primary Outcome
How harmful participant perceives the product to be. Participants will answer a survey item, How harmful do you think this product is to your health; with response options ranging from 0-Not at all harmful to 4-Extremely harmful.
Interventions
- OTHER Tobacco-free
- OTHER Discrete
- OTHER Convenient
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,133 participants |
| Start Date | 2025-05-12 |
| Est. Completion | 2025-11-18 |
| Phase | NA |
What the finished NCT06605924 record still lists
NCT06605924 is an interventional study that assigns participants to a tested intervention. Its 5,133 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (266% higher).
The record links to 0 conditions, and to 3 interventions - of which Tobacco-free is the first listed.
NCT06605924 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06605924 about?
NCT06605924 is a clinical study titled "Oral Nicotine Pouch Marketing Features Influence on Perceptions". This study tests the effects of three oral nicotine marketing features on product perceptions.
What is the current status of trial NCT06605924?
This trial is currently completed. It is a NA study. The enrollment target is 5,133 participants. The study started on 2025-05-12. Estimated completion is 2025-11-18.
What interventions are being tested in trial NCT06605924?
The interventions under investigation include: Tobacco-free (OTHER), Discrete (OTHER), Convenient (OTHER).
Who is sponsoring clinical trial NCT06605924?
This trial is sponsored by Johns Hopkins Bloomberg School of Public Health, which has 187 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06605924's enrollment target sits among peer trials
5,133 25th of 2000 higher than 1,976 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06535867 · 5,122 participants
The Efficacy of Conventional Screening Versus mHealth Screening in Early Detection of Oral Potentially Malignant Disorders and Oral Cancer Amongst the Rural Population of Varanasi: A Prospective and Blinded Study
- NCT05018611 · 5,100 participants · NA
Digital Limited Interaction Efficacy Trial of LifeSkills Mobile to Reduce HIV Incidence in YTW
- NCT05701358 · 5,100 participants · NA
Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease
- NCT05135403 · 5,179 participants
ASSURE WCD Clinical Evaluation - Post Approval Study (ACE-PAS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI